News

Filter

Current filters:

AnalgesiaUSA

1 to 9 of 18 results

FDA declines to expand approval of Pacira's Exparel for postsurgical analgesia

FDA declines to expand approval of Pacira's Exparel for postsurgical analgesia

03-03-2015

The US Food and Drug Administration has declined to expand the approval of Exparel (bupivacaine), manufactured…

AnalgesiaExparelPacira PharmaceuticalsPharmaceuticalRegulationUSA

Orexo files US patent infringement law suit against Actavis for Abstral

Orexo files US patent infringement law suit against Actavis for Abstral

06-02-2015

Sweden-based pharma company Orexo has filed a patent infringement law suit in the US District Court for…

AbstralActavisAnalgesiaGenericsLegalOrexoUSA

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

09-01-2015

UK-based GW Pharmaceuticals and Japanese drugmaker Otsuka have reported that Sativex (nabiximols) did…

AnalgesiaGW PharmaceuticalsOncologyOtsuka PharmaceuticalPharmaceuticalResearchSativexUKUSA

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

Zynerba Pharmaceuticals appoints Richard Baron as vice president and chief financial officer

05-01-2015

Synthetic cannabinoid specialist Zynerba Pharmaceuticals has appointed Richard Baron as vice president…

AnalgesiaBoardroomPharmaceuticalUSAZynerba Pharmaceuticals

Durect to ‘refine the path’ of Posidur program

Durect to ‘refine the path’ of Posidur program

12-11-2014

US drugmaker Durect Corporation says that it has received meeting minutes from its face-to-face meeting…

AnalgesiaDurectPharmaceuticalPosidurRegulationUSA

Relmada appoints Julie Chen as Director of Finance and Operations

02-10-2014

US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance…

AnalgesiaBoardroomPharmaceuticalRelmada TherapeuticsUSA

Actavis files ANDA for generic of Purdue's Butrans

Actavis files ANDA for generic of Purdue's Butrans

26-09-2014

Ireland-headquartered generics major Actavis has filed an Abbreviated New Drug Application with the US…

ActavisAnalgesiaBuprenorphineButransGenericsLegalPurdue PharmaRegulationUSA

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

1 to 9 of 18 results

Back to top